Title

Management of Anticoagulants in the Periprocedural Period for Patients With Cancer

Publication Date

January 2014

Journal Title

Journal of the National Comprehensive Cancer Network

Abstract

Patients with cancer undergo surgeries and procedures for various purposes, including prophylaxis, diagnosis, staging, cure, debulking, palliation, and reconstruction. The diagnosis of cancer itself, along with the well-established complication of venous thromboembolism (VTE), places these patients at risk for perioperative thromboembolism. It is also well-established that continuing patients on oral anticoagulation therapy during the periprocedural period is associated with an increased risk of bleeding. Rates of periprocedural VTE and major bleeding are significantly higher in patients with cancer, presenting a complex problem for clinicians in terms of periprocedural anticoagulation management. This article reviews the current recommendations regarding periprocedural anticoagulation management in patients with cancer.

Volume Number

12

Issue Number

12

Pages

1713-1720

Document Type

Article

EPub Date

2014/12/17

Facility

School of Medicine

Primary Department

Medicine

PMID

WOS:000346190900009

This document is currently not available here.


Share

COinS